Authors: Budai, B Szamel, I Sulyok, Z Nemet, M Bak, M Otto, S Reed, MJ Purohit, A Parish, DC Kralovanszky, J

Citation: B. Budai et al., Characteristics of cystic breast disease with special regard to breast cancer development, ANTICANC R, 21(1B), 2001, pp. 749-752

Authors: Budai, B Szamel, I Sulyok, Z Nemeth, M Bak, M Kralovanszky, J Otto, S Besznyak, I Purohit, A Parish, DC Reed, MJ

Citation: B. Budai et al., Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk, ANTICANC R, 20(5C), 2000, pp. 3879-3886

Authors: Pap, E Erdelyi-Toth, V Kralovanszky, J

Citation: E. Pap et al., High-performance liquid chromatographic determination of busulfan in plasma, CHROMATOGR, 51, 2000, pp. S188-S192

Authors: Katona, C Timar, F Jeney, A Fischel, JL Milano, G Pandi, E Kralovanszky, J

Citation: C. Katona et al., Modulation of 5-fluorouracil by 5-ethyl-2 '-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities, ANTI-CANC D, 10(6), 1999, pp. 561-567

Authors: Kralovanszky, J Katona, C Jeney, A Pandi, E Noordhuis, P Erdelyi-Toth, V Otvos, L Kovacs, P Van der Wilt, CL Peters, GJ

Citation: J. Kralovanszky et al., 5-ethyl-2 '-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil, J CANC RES, 125(12), 1999, pp. 675-684

Authors: Pap, E Erdelyi-Toth, V Kralovanszky, J

Citation: E. Pap et al., High-performance liquid chromatographic determination of dibromomannitol in plasma, CHROMATOGR, 48(1-2), 1998, pp. 17-19